Cargando…
299. Tolerance and Serum Concentration of Cefepime Used Subcutaneously (SC) in the Management of Bone and Joint Infections
BACKGROUND: Cefepime is a cephalosporin active against most Gram positive and negative bacteria and is used in the management of bone and joint infections (BJIs). Intravenous (IV) perfusion is the standard route of administration. The Subcutanoeous (SC) route may present an interesting alternative i...
Autores principales: | Assaf, Addy, Robineau, Olivier, Titecat, Marie, Allorge, Delphine, Hennart, Benjamin, Loyez, Caroline, Migaud, Henri, Senneville, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253334/ http://dx.doi.org/10.1093/ofid/ofy210.310 |
Ejemplares similares
-
315. Oral Vs. Intravenous Antibiotic Treatment for Gram-Positive Prosthetic Joint Infections: A Retrospective Study
por: Coehlo, Alexandre, et al.
Publicado: (2018) -
Challenging Methicillin Resistance Detection in Bone and Joint Infections: Focus on the MRSA/SA SSTI® Strategy
por: Titécat, Marie, et al.
Publicado: (2021) -
Daptomycin versus Vancomycin as Post-Operative Empirical Antibiotic Treatment for Prosthetic Joint Infections: A Case-Control Study
por: Joseph, C, et al.
Publicado: (2019) -
Tolerance of Prolonged Oral Tedizolid for Prosthetic Joint Infections: Results of a Multicentre Prospective Study
por: Senneville, Eric, et al.
Publicado: (2020) -
Ceftobiprole: a potential empirical post-operative monotherapy in prosthetic joint infections
por: Duployez, Claire, et al.
Publicado: (2020)